Figures and data in Acute perturbation of Pet1-neuron activity in neonatal mice impairs cardiorespiratory homeostatic recovery

Figures
Tables
Additional files

7 figures, 3 tables and 1 additional file

Figures

Figure 1 with 1 supplement

Download asset Open asset

Genetic mouse model and postneonatal autoresuscitation assay.

(**A–C”’**) HA-tagged Di receptor expression targeted to *Pet1*-raphe serotonergic neurons in double-transgenic *Pet1-Flpe;* RC-FDi (referred to as *Pet1-Di*) pups at P8, as shown previously in adult mice (Brust et al., 2014). (**A–C**) Low magnification view of 20 µm coronal section showing neurons immunopositive for tryptophan hydroxylase 2 (Tph2), identifying serotonergic neurons in the dorsal raphe nucleus (DRN) (A), the raphe magnus nucleus (RMg) (B), and the raphe obscurus (ROb) (C). Fields demarcated by dashed rectangles in **A–C** are shown at higher magnification in **A’–C’”**, with Tph2 immunoreactivity again in green (**A’–C’**), HA-Di immunopositivity in red (**A”–C”**), serotonin (5-HT) immunopositivity in magenta (**A”’–C”’**), and dashed cell outlines as grossly determined by the Tph2 immunodetection signal. The raphe location, proportion, and intensity of HA-Di immunodetection signal was qualitatively similar across *Pet1-Di* pups from independent litters (Figure 1—figure supplement 1). (**D–F**) Representative fields from negative-control single transgenics harboring the unrecombined RC-FDi allele (referred to as Control-Di), showing no detectable HA-Di, in line with prior validation that Di-expression from RC-FDi requires Flpe-recombination. Insets show Tph2 immunodetection of serotonergic neurons in these fields. Scale bars in **A–C** equal 50 µm, and in **A’–C””** and D-F, 10 µm. (**G–H**) Schematic of repeated asphyxia-induced apnea and autoresuscitation recovery, during which breath size and heart rate are continuously monitored. (G) Plethysmograph chamber oxygen (O₂) percent across assay time, starting with ~20 min of pup acclimation to chamber air (21% O₂) including extraction of baseline cardiorespiratory values during the temporal window indicated by the open rectangle a. I.P. injection of CNO immediately follows; red rectangle indicates CNO exposure window. Asphyxia-apnea bouts are indicated by the four periods (b–e) of ~0% O₂ (97% N₂, 3% CO₂) shown in gray. (H) Temporally expanded view of an asphyxia-apnea bout including example tracing of breath size (and calculated breathing rate, BR) and heart rate (HR) over time. Primes (b’ and similarly for c-e) indicate the bout-specific baseline post CNO injection immediately preceding asphyxia. The gray window indicates the period of asphyxia that induced the apnea, which is followed by immediate return to 21% O₂ during which autoresuscitation recovery ensues. Black bars after asphyxia indicate τ_f or τ_HR (τ defined as 63% of the baseline value before that specific asphyxic bout). Light gray box indicates period of asphyxia (97% N 3% CO₂) used to induce the apnea.

https://doi.org/10.7554/eLife.37857.003

Figure 1—figure supplement 1

Download asset Open asset

Additional examples of HA-Di expression in medullary brain tissue of *Pet1-Di* pups from independent litters.

(**A–D”’**) HA-tagged Di receptor expression targeted to *Pet1*-raphe serotonergic neurons in double-transgenic *Pet1-Flpe;* RC-FDi (referred to as *Pet1-Di*) pups at P8, as shown in Figure 1. **A-A’’** and **C-C’’’** are from the same pup, which is distinct from the pup (and litter) source for the tissue in **B-B’’’** and **D–D’”**, and from that in Figure 1. (**A–D**) Low magnification view of 20 µm coronal section showing neurons immunopositive for tryptophan hydroxylase 2 (Tph2), identifying serotonergic neurons in the raphe magnus nucleus (RMg) (**A–B**) and the raphe obscurus (ROb) (**C–D**). Dashed rectangles in **A–D** are shown at higher magnification in **A’-D’”**, with Tph2 immunoreactivity in green (**A’–D’**), HA-Di immunopositivity in red (**A”–D”**), serotonin (5-HT) immunopositivity in magenta (**A”’–D”’**), and dashed cell outlines (white) as determined by the Tph2 signal. Scale bars: **A–D**, 50 µm; **A’–D’’’**, 10 µm.

https://doi.org/10.7554/eLife.37857.004

Figure 2 with 3 supplements

Download asset Open asset

Acute perturbation of *Pet1* neurons alters baseline cardiorespiratory values.

(**A–B’**) A and B represent minute ventilation ( ${\dot{V}}_{E}$ , ml min⁻¹ •kg⁻¹) and heart rate (HR, beats per minute, bpm), respectively, in sibling controls harboring the unrecombined RC-FDi allele (non-Di-expressors referred to as Control-Di) before and during CNO exposure. No detectable change was observed in ${\dot{V}}_{E}$ or HR before and during CNO exposure. (**A’ and B’**) show ${\dot{V}}_{E}$ and HR, respectively, before and during CNO-induced disruption of *Pet1-*neurons in double transgenic *Pet1-Flpe*, RC-FDi (Di-expressors, referred to as *Pet1-Di*) pups. Coefficient-of-variation calculations for breathing f and HR during CNO exposure versus baseline prior to CNO injection are presented in Figure 2—figure supplement 1. (**C–C’**) Linear regression of pre-CNO ${\dot{V}}_{E}$ plotted against change in ${\dot{V}}_{E}$ for control-Di pups (C) (correlation p=0.47 and R² = 0.04) and *Pet1-Di* pups (C’) (correlation p<0.0001 and R² = 0.76). (**D–D’**) Linear regression of pre-CNO HR plotted against change in HR for control-Di pups (D) (correlation p=0.52 and R² = 0.03) and *Pet1-Di* pups (D’) (correlation p=0.45 and R² = 0.03). Abbreviation $\dot{V_{E}}_{P r e}$ (ventilation prior to CNO injection), ${\dot{V}}_{E}_{C N O}$ (ventilation during CNO exposure), HR_Pre (heart rate prior to CNO injection), HR_CNO (heart rate during CNO exposure), bpm (beats per minute), mL (milliliters), min (minutes), kg (kilograms). ‘Dies’ refers to pups that go on to die in future bouts – red lines (**A–B’**) and red circles (**C–D’**), ‘survives’ refers to pups that survive the full set of asphyxic-apnea challenges – gray lines (**A–B’**) and black circles (**C–D’**). Linear regression of pre-CNO ${\dot{V}}_{E}$ plotted against change in HR, and change in ${\dot{V}}_{E}$ plotted against change in HR are presented in Figure 2—figure supplement 2. Ventilatory equivalents for oxygen ( ${\dot{V}}_{E} / {\dot{V}}_{O_{2}}$ ) and oxygen consumption ${\dot{V}}_{O_{2}}$ data pre- versus during CNO exposure are plotted in Figure 2—figure supplement 3.

https://doi.org/10.7554/eLife.37857.006

Figure 2—figure supplement 1

Download asset Open asset

Variation in heart rate and respiratory rate.

(**A–A’**) Plotted coefficient of variation for respiratory rate determined across the 30 s stable trace analyzed in Figure 2 (and described in the Methods section) for pre- versus CNO exposure (measurement window a versus b’ illustrated in Figure 1G and H) for control-Di pups (A) and *Pet1-Di* pups (A’). (**B–B’**) Plotted coefficient of variation for heart rate across the 30 s stable trace analyzed in Figure 2 for pre- versus CNO exposure for control-Di pups (B) and *Pet1-Di* pups (B’). Gray dots represent pups that survived all four asphyxia-induced apnea bouts. Red dots represent pups that go on to die. Black dot represents the mean of all pups in that cohort.

https://doi.org/10.7554/eLife.37857.007

Figure 2—figure supplement 2

Download asset Open asset

Changes in baseline heart rate in relation to ventilation.

(**A–A’**) Linear regression of pre-CNO minute ventilation ( ${\dot{V}}_{E}$ •min⁻¹•kg⁻¹) plotted against change in heart rate (HR, bpm) for control-Di pups (A) and *Pet1-Di* pups (A’). (**B–B’**) Linear regression of Δ ${\dot{V}}_{E}$ (during versus before CNO exposure) plotted against change in heart rate (ΔHR, bpm) for control-Di pups (B) and *Pet1-Di* pups (B’). Abbreviations: $\dot{V_{E}}_{P r e}$ (ventilation prior to CNO), $\dot{V_{E}}_{C N O}$ (ventilation during CNO exposure), HR_Pre (heart rate prior to CNO), HR_CNO (heart rate during CNO exposure), bpm (beats per minute), mL (milliliters), min (minutes), kg (kilograms). Red dots represent pups that go on to die in future bouts; black dots represent pups that survive.

https://doi.org/10.7554/eLife.37857.008

Figure 2—figure supplement 3

Download asset Open asset

Analyses of ventilatory equivalents for oxygen and oxygen consumption before and during CNO exposure.

(**A–B’**) A and B represent ventilatory equivalents for oxygen ( ${\dot{V}}_{E} / {\dot{V}}_{O_{2}}$ ) and maximal oxygen consumption ( ${\dot{V}}_{O_{2}}$ , ml • min⁻¹ • g⁻¹), respectively, in sibling controls harboring the unrecombined RC-FDi allele (non-Di-expressors referred to as Control-Di) before and during CNO exposure; A’ and B’ represent such measurements for double transgenic *Pet1-Flpe*, RC-FDi pups (Di-expressors, referred to as *Pet1-Di*). ${\dot{V}}_{E} / {\dot{V}}_{O_{2}}$ before versus during CNO exposure showed no statistically significant differences for either Control-Di (A) or *Pet1-Di* (A’) pups. ${\dot{V}}_{O_{2}}$ values generally decreased following CNO and return to the pleythysmograph chamber for both genotypes (**B, B’**). (**C–C’**) Linear regression of pre-CNO ${\dot{V}}_{E} / {\dot{V}}_{O_{2}}$ (x-axis) plotted against change in ${\dot{V}}_{E} / {\dot{V}}_{O_{2}}$ for control-Di pups (C) (correlation p=0.43 and R² = 0.05) and *Pet1-Di* pups (C’) (correlation p=0.12 and R² = 0.12). (**D–D’**) Linear regression of pre-CNO ${\dot{V}}_{O_{2}}$ plotted against change in ${\dot{V}}_{O_{2}}$ for control-Di pups (D) (correlation p<0.0001 and R² = 0.80) and *Pet1-Di* pups (D’) (correlation p=0.030 and R² = 0.21). Abbreviation ${\dot{V}}_{E} / {\dot{V}}_{O_{2}}_{P r e}$ (ventilatory equivalents for oxygen prior to CNO injection), ${\dot{V}}_{E} / {\dot{V}}_{O_{2}}_{C N O}$ (ventilatory equivalents for oxygen during CNO exposure), ${\dot{V}}_{O_{2}}_{P r e}$ (maximal oxygen consumption prior to CNO injection), ${\dot{V}}_{O_{2}}_{C N O}$ (maximal oxygen consumption during CNO exposure). ‘Dies’ refers to pups that go on to die in future bouts – red lines (**A–B’**) and red circles (**C–D’**), ‘survives’ refers to pups that survive the full set of asphyxic-apnea challenges – gray lines (**A–B’**) and black circles (**C–D’**).

https://doi.org/10.7554/eLife.37857.009

Figure 3

Download asset Open asset

Acutely disrupting *Pet1-*neuron activity impairs pup ability to recover from multiple apneas.

(A) Percent mortality after repeated asphyxia-induced apneas plotted as a function of genotype (one-sided Fisher’s Exact Test with Lancaster’s Mid P correction p=0.041). (B) Example breathing and heart rate response trace from a *Pet1-Di-*CNO pup that failed to recover. Gray box indicates the window of asphyxic conditions (97% N 3% CO₂). n = 15 for control-*Di-*CNO pups, n = 22 for *Pet1-Di-*CNO pups.

https://doi.org/10.7554/eLife.37857.010

Figure 4

Download asset Open asset

Acutely disrupting *Pet1-*neuron activity primarily affects respiratory components during apnea recovery

(A) Compressed schematic of autoresuscitation assay timeline indicating asphyxia-apnea bouts and data extraction windows; open windows *a’-d’* reflect bout-specific baseline measurements, filled windows *a-d* reflect temporally when recovery to 63% of baseline values was determined (τ_f and τ_HR). (**B and D**) τ_f (B) or τ_HR (D) across bouts, with open ‘Fatalities’ rectangle above each graph denoting animals that died during the assay; the contained shapes represent the fatal apnea bout – diamond (bout 1), triangle (bout 3), square (bout 4) – while black fill reflects mortality during that recovery response. *Pet1-Di*-CNO pups indicated in red (n = 22), control-*Di-*CNO pups (sibling non-Di-expressors), in blue (n = 15). (**C and E**) τ_f (C) or τ_HR (E) during the last-recovered bout (final bout during which a pup was able to achieve 63% of baseline characteristic). Black-fill continues to reflect mortality, shape reflects bout that was fatal. Gray-filled shapes reflect animals that recovered HR to 63% of baseline although went on to die during that apnea bout despite meeting τ_HR criteria. Plotted circles reflect pups that survived all bouts; +indicates the mean; box-whisker plot shows median as the horizontal line, 1^st and 3^rd quartiles as the ‘box,’ and maximum and minimum values as the ‘whiskers.’.

https://doi.org/10.7554/eLife.37857.011

Figure 5 with 1 supplement

Download asset Open asset

*Pet1-Di-*CNO pups show a decoupling of heart rate and breathing rate recovery times.

(**A–A”**) Scatter plot of recovery τ_f (seconds, s) versus τ_HR (s) that includes all possible apnea recoveries of both groups, with data points from *Pet1-Di*-CNO pups in red, and *control-Di-*CNO pups in blue, superimposed for ease in comparing. For additional clarity, results from each group are presented separately in A’, control-Di-CNO; and A”, *Pet1-Di-*CNO. Similar scatter plots but only including recovery data from the first asphyxia-apnea bout (**B–B”**), from bout 2 (**C–C”**), bout 3 (**D–D”**), and bout 4 (**E–E”**). Solid lines reflect a linear regression with dotted lines denoting 95% confidence intervals. Black filled shapes represent fatal bouts – diamond (bout 1), triangle (bout 3), square (bout 4). Circles reflect pups that survived all bouts. ** (p<0.01). Illustrative breathing and HR recovery tracings from a *Pet1-Di-*CNO pup and a Control-Di-CNO pup are presented in Figure 5—figure supplement 1.

https://doi.org/10.7554/eLife.37857.012

Figure 5—figure supplement 1

Download asset Open asset

Example traces showing differential breathing and HR recovery responses to asphyxia-induced apnea in a *Pet1-Di-*CNO pup (A) as compared to control (B).

In each panel (**A, B**), the top trace reflects breathing response expressed as the raw tracing with millivolts (mV) reflecting breath size; bottom trace reflects HR in beats per min (bpm). Gray-shaded extent reflects recovery duration to achieve 63% of pre-bout baseline level.

https://doi.org/10.7554/eLife.37857.013

Figure 6 with 2 supplements

Download asset Open asset

*Pet1-Di-*CNO pups demonstrate a disordered gasp response to the initial asphyxic bout and induced apnea.

(A) Example respiratory traces immediately following the first asphyxia-induced apnea: top trace, from a *Pet1-Di*-CNO pup that goes on to die during a subsequent bout; bottom trace, from a control-Di-CNO pup (non-Di-expressor). Illustrated are differences in gasp characteristics and components that are plotted in **B–D**. (B) First gasp size (normalized to body weight). (C) Time to first gasp during initial apnea. (D) Time difference (s, seconds) between gasp intervals. (E) Mean heart rate (HR) between gasp intervals. (F) Baseline ventilatory equivalents per oxygen, ${\dot{V}}_{E} / {\dot{V}}_{O_{2}}$ , prior to CNO administration in relation to genotype coupled with CNO exposure (neuron perturbation) and assay survival. Abbreviations: (I–IV) – time difference (s) between 1^st and 2^nd (I), 2^nd and 3^rd (II), 3^rd and 4^th (III), or 4^th and 5^th (IV) gasps, respectively. Red * or bracket compares *Pet1-Di*-CNO pups that go on to die versus *Pet1-Di*-CNO pups that survive. Blue * or bracket compares *Pet1-Di*-CNO pups that go on to die versus control-Di-CNO pups that survive. Shapes representing fatal bout – diamond (bout 1), triangle (bout 3), square (bout 4). Circles represent pups that survived all bouts. * (p<0.05) and **** (p<0.0001). Variability of baseline breathing and HR pre- versus during CNO exposure (prior to any asphyxic-apnea challenge) for *Pet1-Di* and control-Di pups is analyzed in Figure 6—figure supplement 1 and Figure 6—figure supplement 2, respectively.

https://doi.org/10.7554/eLife.37857.014

Figure 6—figure supplement 1

Download asset Open asset

Variability for the baseline room air interbreath interval in Control-Di and *Pet1-Di* pups prior to and during CNO exposure.

(**A–C**) Control-Di pups; (**A’–C’**) *Pet1-Di* pups; gray dots reflect pups that survived all four asphyxia-induced apnea challenges; red dots, pups that died during the assay; black dots reflect the mean; box-whisker plot shows median as the horizontal line, 1^st and 3^rd quartiles as the ‘box,’ and maximum and minimum values as the ‘whiskers.’ Variability expressed as (**A, A’**) the standard deviation (SD) of the interbeat interval, (**B, B’**) the product of the length times the width of the distribution of the Poincare plot, and (**C, C’**) the root mean square of successive differences (RMSSD). Significant differences pre- versus during CNO exposure were detected for *Pet1-Di* mice (**A’ and B’** as well when limiting analyses to animals that died).

https://doi.org/10.7554/eLife.37857.015

Figure 6—figure supplement 2

Download asset Open asset

Variability for the baseline room air interbeat interval in Control-Di and *Pet1-Di* pups prior to and during CNO exposure.

(**A–C**) Control-Di pups; (**A’–C’**) *Pet1-Di* pups; gray dots reflect pups that survived all four asphyxia-induced apnea challenges; red dots, pups that died during the assay; black dots reflect the mean; box-whisker plot shows median as the horizontal line, 1^st and 3^rd quartiles as the ‘box,’ and maximum and minimum values as the ‘whiskers.’ Variability expressed as (**A, A’**) the standard deviation (SD) of the interbeat interval, (**B, B’**) the product of the length times the width of the distribution of the Poincare plot, and (**C, C’**) the root mean square of successive differences (RMSSD). No significant differences pre- versus during CNO exposure were detected for either genotype.

https://doi.org/10.7554/eLife.37857.016

Figure 7

Download asset Open asset

Proposed *Pet1*-neuron involvement in the postneonatal autoresuscitation response to apneas.

(A) In control pups (unrecombined RC-FDi allele harboring, non-Di expressors exposed to CNO), an apnea (with associated bradycardia) would lead to blood/tissue oxygen tension (PO₂) reduction and carbon dioxide tension (PCO₂) elevation, which in turn would stimulate *Pet1* raphe neuron activity along with other brainstem areas to trigger gasping, resulting in homeostatic PO₂ elevation and PCO₂ reduction enabling heart and breathing rate recovery, which occurs in a linearly coupled fashion, ultimately restoring life-supporting PO₂ and PCO₂ levels. (B) In *Pet1-Di-*CNO pups in which *Pet1* neurons are acutely perturbed, the initial gasp response is disordered and diminished, as is the breathing rate recovery, which becomes decoupled from the more normal heart rate recovery trajectory. Collectively this leads to prolonged and potentially life-threatening PO₂ andPCO₂ levels. (C) Worsening yet is when spontaneous conditions of hyperventilation (elevated ${\dot{V}}_{E} / {\dot{V}}_{O_{2}}$ ) couple with *Pet1* neuron perturbation. The dual insult results in diminished collective drive across *Pet1* and other neuron types, resulting in greater impairment in gasping and a more severe decoupling of the breathing and heart rate recovery responses, increasing significantly the risk likelihood of death.

https://doi.org/10.7554/eLife.37857.018

Tables

Table 1

Baseline cardiorespiratory values prior to CNO-induced disruption of Pet1-neurons.

Data (mean ±standard deviation) for each time point were obtained prior to CNO-induced silencing (Figure 1G open window a). Student’s t-test was used to assess differences between genotypes.

https://doi.org/10.7554/eLife.37857.005

	RC-FDi(Control-Di)n=15		Pet1-Flpe;RC-FDi(Pet1-Di)n=22
Mouse baseline characteristics	Mean	SD	Mean	SD	t-test p value
Weight (BW) (g)	5.503	1.115	5.04	1.275	0.2616
Breathing frequency (ƒ) (breaths • min⁻¹)	241.6	26.87	246.3	30.93	0.6406
Tidal volume (V_T) (ml • g⁻¹)	4.51	1.034	4.757	1.784	0.6322
Minute ventilation ( ${\dot{V}}_{E}$ ) (ml • min⁻¹ • g⁻¹)	1070	169.9	1139	331.9	0.4618
Heart rate (HR) (bpm)	634.6	40.88	612.8	42.01	0.1271
Oxygen consumption ( ${\dot{V}}_{O_{2}}$ ) (ml • min⁻¹ • g⁻¹)	77.43	19.19	71.25	14.39	0.2705
Ventilatory equivalents ( ${\dot{V}}_{E} / {\dot{V}}_{O_{2}}$ )	14.33	2.989	16.13	3.741	0.1281

Table 2

Mortality by homeostatic characteristics prior to neuron perturbation.

Logistic regression results of different homeostatic characteristics and mortality outcomes of Pet1-Di-CNO pups.

https://doi.org/10.7554/eLife.37857.017

Baseline characteristic	Odds ratio	Confidence interval		p-value*
Heart rate	1.017	0.994	1.040	0.15
Ventilation	1.001	0.999	1.004	0.38
Maximum Oxygen Consumption	0.965	0.907	1.026	0.25
Ventilatory Equivalents	1.399	1.039	1.883	0.027

*logistic regression, controlling for genotype

Key resources table

Reagent type (species) or resource	Designation	Source or reference	Identifiers	Additional information
Genetic reagent (M. musculus)	Pet1-Flpe	PMID: 18344997		Dr. Susan Dymecki (Department of Genetics, Harvard Medical School)
Genetic reagent (M. musculus)	RC-FDi Gt(ROSA)26Sor^{tm(CAG-FSF-CHRM4*(Di))Dym}	PMID: 21798952	derivative of MGI:5790683 Gt(ROSA)26Sor^{tm9(CAG-mCherry,-CHRM4*)Dym}	Dr. Susan Dymecki (Department of Genetics, Harvard Medical School)
Antibody	Rabbit polyclonal anti-Tph2	Novus Biological	Cat. #: NB100-74555 RRID:AB_1049988	IHC (1:1000)
Antibody	Rat monoclonal anti-HA	Chromotek	Cat. # 7C9 RRID: AB_2631399	IHC (1:200)
Antibody	Goat polyclonal anti-5-HT	Abcam	Cat. # ab66047 RRID:AB_1142794	IHC (1:1000)
Antibody	Donkey anti-rabbit IgG-Alexa Fluor 488	ThermoFisher Scientific	Cat. # A-21206 RRID:AB_2535792	IHC (1:500)
Antibody	Donkey anti-rat IgG-Alexa Fluor 594	ThermoFisher Scientific	Cat. # A-21209 RRID:AB_2535795	IHC (1:500)
Antibody	Donkey anti-goat igG-Alexa Fluor 647	ThermoFisher Scientific	Cat. # A-21447 RRID:AB_2535864	IHC (1:500)
Recombinant DNA reagent	Flpe forward primer	5’-GCATCTGGGAGATCACTGAG-3’		PCR genotyping
Recombinant DNA reagent	Flpe reverse primer	5’-CCCATTCCATGCGGGGTATCG-3’		PCR genotyping
Recombinant DNA reagent	FDi forward primer	5’-CGAATTCGGAAACATAACTTCG-3’		PCR genotyping
Recombinant DNA reagent	FDi reverse primer	5’-GGCAATGAAGACTTTCCACCG-3’		PCR genotyping
Chemical compound, drug	clozapine-N-oxide (CNO)	Sigma	Cat. # C0832	fresh stock solution 1 mg/ml in saline
Chemical compound, drug	DAPI (4', 6-diamidino-2-phenylindole)	ThermoFisher Scientific	Cat. # D1306	nuclear counter staining, final concentraion at 5 µg/mL

Additional files

Transparent reporting form: https://doi.org/10.7554/eLife.37857.019
Download elife-37857-transrepform-v1.docx

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Mendeley

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

Ryan T Dosumu-Johnson
Andrea E Cocoran
YoonJeung Chang
Eugene Nattie
Susan M Dymecki

(2018)

Acute perturbation of Pet1-neuron activity in neonatal mice impairs cardiorespiratory homeostatic recovery

eLife 7:e37857.

https://doi.org/10.7554/eLife.37857

Figures

Genetic mouse model and postneonatal autoresuscitation assay.

Additional examples of HA-Di expression in medullary brain tissue of Pet1-Di pups from independent litters.

Acute perturbation of Pet1 neurons alters baseline cardiorespiratory values.

Variation in heart rate and respiratory rate.

Changes in baseline heart rate in relation to ventilation.

Analyses of ventilatory equivalents for oxygen and oxygen consumption before and during CNO exposure.

Acutely disrupting Pet1-neuron activity impairs pup ability to recover from multiple apneas.

Acutely disrupting Pet1-neuron activity primarily affects respiratory components during apnea recovery

Pet1-Di-CNO pups show a decoupling of heart rate and breathing rate recovery times.

Example traces showing differential breathing and HR recovery responses to asphyxia-induced apnea in a Pet1-Di-CNO pup (A) as compared to control (B).

Pet1-Di-CNO pups demonstrate a disordered gasp response to the initial asphyxic bout and induced apnea.

Variability for the baseline room air interbreath interval in Control-Di and Pet1-Di pups prior to and during CNO exposure.

Variability for the baseline room air interbeat interval in Control-Di and Pet1-Di pups prior to and during CNO exposure.

Proposed Pet1-neuron involvement in the postneonatal autoresuscitation response to apneas.

Tables

Baseline cardiorespiratory values prior to CNO-induced disruption of Pet1-neurons.

Mortality by homeostatic characteristics prior to neuron perturbation.

Additional files

Transparent reporting form

Download links

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

Be the first to read new articles from eLife

Share this article

Cite this article

Genetic mouse model and postneonatal autoresuscitation assay.

Additional examples of HA-Di expression in medullary brain tissue of Pet1-Di pups from independent litters.

Acute perturbation of Pet1 neurons alters baseline cardiorespiratory values.

Variation in heart rate and respiratory rate.

Changes in baseline heart rate in relation to ventilation.

Analyses of ventilatory equivalents for oxygen and oxygen consumption before and during CNO exposure.

Acutely disrupting Pet1-neuron activity impairs pup ability to recover from multiple apneas.

Acutely disrupting Pet1-neuron activity primarily affects respiratory components during apnea recovery

Pet1-Di-CNO pups show a decoupling of heart rate and breathing rate recovery times.

Example traces showing differential breathing and HR recovery responses to asphyxia-induced apnea in a Pet1-Di-CNO pup (A) as compared to control (B).

Pet1-Di-CNO pups demonstrate a disordered gasp response to the initial asphyxic bout and induced apnea.

Variability for the baseline room air interbreath interval in Control-Di and Pet1-Di pups prior to and during CNO exposure.

Variability for the baseline room air interbeat interval in Control-Di and Pet1-Di pups prior to and during CNO exposure.

Proposed Pet1-neuron involvement in the postneonatal autoresuscitation response to apneas.

Baseline cardiorespiratory values prior to CNO-induced disruption of Pet1-neurons.

Mortality by homeostatic characteristics prior to neuron perturbation.

Transparent reporting form

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)